Cardia Bioplastics (ASX:CNN) Inventory-to-Revenue : 0.61 (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Cardia Bioplastics Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Cardia Bioplastics's Average Total Inventories for the quarter that ended in Dec. 2023 was A$3.77 Mil. Cardia Bioplastics's Revenue for the six months ended in Dec. 2023 was A$6.19 Mil. Cardia Bioplastics's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.61.

Cardia Bioplastics's Inventory-to-Revenue for the quarter that ended in Dec. 2023 increased from Jun. 2023 (0.47) to Jun. 2023 (0.61)

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Cardia Bioplastics's Days Inventory for the six months ended in Dec. 2023 was 134.78.

Inventory Turnover measures how fast the company turns over its inventory within a year. Cardia Bioplastics's Inventory Turnover for the quarter that ended in Dec. 2023 was 1.35.

Cardia Bioplastics Inventory-to-Revenue Historical Data

The historical data trend for Cardia Bioplastics's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardia Bioplastics Inventory-to-Revenue Chart

Cardia Bioplastics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Inventory-to-Revenue

Get a 7-Day Free Trial

0.13

0.12

0.13

0.21

0.26

Cardia Bioplastics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Inventory-to-Revenue	Get a 7-Day Free Trial															0.46	0.52	0.60	0.47	0.61

Competitive Comparison of Cardia Bioplastics's Inventory-to-Revenue

For the Packaging & Containers subindustry, Cardia Bioplastics's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cardia Bioplastics's Inventory-to-Revenue Distribution in the Packaging & Containers Industry

For the Packaging & Containers industry and Consumer Cyclical sector, Cardia Bioplastics's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Cardia Bioplastics's Inventory-to-Revenue falls into.

Cardia Bioplastics Inventory-to-Revenue Calculation

Cardia Bioplastics's Inventory-to-Revenue for the fiscal year that ended in Jun. 2023 is calculated as

	Inventory-to-Revenue (A: Jun. 2023 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (A: Jun. 2022 )	+	Total Inventories (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )
=	( (7.841	+	4.095)	/	2 )	/	22.836
=	5.968					/	22.836
=	0.26

Cardia Bioplastics's Inventory-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

	Inventory-to-Revenue (Q: Dec. 2023 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (Q: Jun. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Revenue (Q: Dec. 2023 )
=	( (4.095	+	3.444)	/	2 )	/	6.193
=	3.7695					/	6.193
=	0.61

Cardia Bioplastics (ASX:CNN) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Cardia Bioplastics's Days Inventory for the six months ended in Dec. 2023 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2023 )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
	=	3.7695	/	5.104	*	365 / 2
	=	134.78

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Cardia Bioplastics's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2023 )	/	Average Total Inventories (Q: Dec. 2023 )
	=	5.104	/	3.7695
	=	1.35

Cardia Bioplastics Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cardia Bioplastics's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Cardia Bioplastics (ASX:CNN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Packaging & Containers » Cardia Bioplastics Ltd (ASX:CNN) » Definitions » Inventory-to-Revenue

Comparable Companies

Traded in Other Exchanges

SES:Australia

Address

247 Ferntree Gully Road, Unit 1, Mount Waverley, Melbourne, VIC, AUS, VIC 3149

Website

https://www.secosgroup.com.au

SECOS Group Ltd is an Australian developer and manufacturer of sustainable packaging materials. . Business operating segment includes the manufacture and distribution of polyethylene films, renewable resource-based resins, and finished products. It supplies proprietary biodegradable resins, packaging products cast films to a customer base spread globally.SECOS Global Application Development Centre is in Australia. Product Development Centre and manufacturing plant for resins and finished products in China and resins plant in Malaysia. It also has manufacturing plants for cast films in Malaysia. It conducts sales via geographical regions that include Australia, Asia, America, Europe, and Africa. Asia generates maximum revenue for the company.

Cardia Bioplastics (ASX:CNN) Headlines

No Headlines